EDP Sciences logo
Open Access
Ann Toxicol Anal
Volume 25, Numéro 2, 2013
Page(s) 57 - 62
DOI https://doi.org/10.1051/ata/2013040
Publié en ligne 17 septembre 2013
  1. Davidson C, Ramsey J. Desoxypipradrol is more potent than cocaine on evoked dopamine efflux in the nucleus accumbens. J Psychopharmacol. 2012; 26: 1036–1041. [CrossRef] [PubMed] [Google Scholar]
  2. Corkery JM, Elliott S, Schifano F, Corazza O, Ghodse AH. 2-DPMP (desoxypipradrol, 2-benzhydrylpiperidine, 2-phenylmethylpiperidine) and D2PM (diphenyl-2-pyrrolidin-2-yl-methanol, diphenylprolinol) : A preliminary review. Prog Neuropsychopharmacol Biol Psychiatr. 2012; 39: 253–258. [CrossRef] [Google Scholar]
  3. Coppola M, Mondola R. Research chemicals marketed as legal highs : the case of pipradrol derivatives. Toxicol Lett. 2012; 212(1) : 57–60. [CrossRef] [MathSciNet] [PubMed] [Google Scholar]
  4. Turcant A, Prémel-Cabic A, Cailleux A, Allain P. Toxicological screening of drugs by microbore high-performance liquid chromatography with photodiode-array detection and ultraviolet spectral library searches. Clin Chemistry. 1991; 37(7) : 1210–1215. [Google Scholar]
  5. Gruson A et groupe «accréditation» SFTA. Aide à la validation des méthodes en toxicologie et suivi thérapeutique pharmacologique. Ann Toxicol Anal. 2005; S1: 1–20. [Google Scholar]
  6. Kuck D. Half a century of scrambling in organic ions : complete, incomplete, progressive and composite atom interchange. Int J Mass Spectrom. 2002; 213: 101–144. [Google Scholar]
  7. Consideration of Desoxypipradrol (2-DPMP) and related pipradrol compounds. Document consulté le 16 juillet 2012 sur le site http://www.homeoffice.gov.uk/publications/agencies-public-bodies/acmd1/desoxypipradrol-report?view=Binary. [Google Scholar]
  8. James DA, Potts J, Thomas SHL, Chincholkar VM, Clarke S, Dear J, Ramsey J. Clinical features associated with recreational use of «Ivory Wave» preparations containing desoxypipradrol. Clin Toxicol. 2011; 49: 201. [Google Scholar]
  9. Hill SL, Thomas SH. Clinical toxicology of newer recreational drugs. Clin Toxicol (Phila). 2011; 49(8) : 705–719. [CrossRef] [PubMed] [Google Scholar]
  10. ACMD advice on «Ivory Wave». Document consulté le 16 juillet 2012 sur le site http://www.homeoffice.gov.uk/publications/agencies-public-bodies/acmd1/advice-ivory-wave?view=Binary. [Google Scholar]
  11. Murray DB, Potts S, Haxton C, Jackson G, Sandilands EA, Ramsey J, Puchnarewicz M, Holt DW, Johnston A, Nicholas BD, Dear JW. «Ivory wave» toxicity in recreational drug users; integration of clinical and poisons information services to manage legal high poisoning. Clin Toxicol (Phila). 2012; 50(2) : 108–113. [CrossRef] [PubMed] [Google Scholar]
  12. Imports of Desoxypipradrol (2-DPMP, 2-Benzhydrylpiperidine, 2-Diphenylmethylpiperidine). Document consulté le 16 juillet 2012 sur le site http://webarchive.nationalarchives.gov.uk/+/http://www.homeoffice.gov.uk/publications/drugs/drug-licences/desoxypipradrol/. [Google Scholar]
  13. Annual Report on the Home Office Forensic Early Warning System (FEWS) – A System to Identify New Psychoactive Substances in the UK. Document consulté le 16 juillet 2012 sur le site http://www.homeoffice.gov.uk/publications/alcohol-drugs/drugs/drug-strategy/fews?view=Binary. [Google Scholar]
  14. Wood DM, Puchnarewicz M, Johnston A, Dargan PI. A case series of individuals with analytically confirmed acute diphenyl-2-pyrrolidinemethanol (D2PM) toxicity. Eur J Clin Pharmacol. 2012; 68(4) : 349–353. [CrossRef] [PubMed] [Google Scholar]